Recombinant Human BMP-2 Protein, Active

Beta LifeScience SKU/CAT #: BEP-0052

Recombinant Human BMP-2 Protein, Active

Beta LifeScience SKU/CAT #: BEP-0052
Regular price $974.00
/
Size

Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Connect with us via the live chat in the bottom corner to receive immediate assistance.

Product Overview

Product Name Recombinant Human BMP-2 Protein
Target Symbol BMP2
Alternative Names Bone Morphogenetic Protein 2, Bone Morphogenetic Protein 2A, BMP2, BMP2A, BDA2, SSFSC, SSFSC1
Accession Number P12643
Expression System E. coli.
Molecular Weight 13 kDa (monomer, predicted)
Sequence Gln283-Arg396, with an N-terminal Met
Purity Determined by SDS-PAGE and quantitative densitometry by Coomassie® Blue staining
Activity Determined by in-house activity assay
Formulation Lyophilized from sterile PBS with Trehalose, pH 7.4
Endotoxin Level Available Upon Request
Shipping Shipped at ambient temperature.
Stability & Storage 12 months from date of receipt at -20°C to -70°C, lyophilized powder. 3 months at -20°C to -70°C under sterile conditions after reconstitution. Avoid repeated freeze-thaw cycles.
Reconstitution Reconstitute at 100 ug/mL in sterile PBS.
Target Function Bone Morphogenetic Protein 2 (BMP-2) mediates several functions related to cartilage and bone formation. During embryonic development, BMP-2 contributes to dorsal-ventral patterning of the developing neural tube, and influences differentiation of endoderm, mesenchymal cells, and chondrocytes. In response to tissue damage, BMP-2 promotes chondrogenesis, migration of keratinocytes, and angiogenesis. BMP-2 signaling occurs via binding to BMPR1A (CD292) and BMPR2, at which point BMPR2 transphosphorylates BMPR1A to induce the Smad signaling pathway.
Tissue Specificity BMP-2 expression has been identified in ectoderm, mesoderm, endoderm, developing skeletal tissues such as cartilage and bone, the developing central nervous system, including the neural tube and the brain, heart, kidney, lung, and skin.
Cellular Localization Secreted protein
Involvement In Disease Dysregulation of BMP-2 is associated with osteoporosis, atherosclerosis, congenital heart defects, Alzheimer’s disease, Parkinson’s disease, insulin resistance, type 2 diabetes, osteoarthritis, and various cancers due to BMP-2 enhanced invasion and metastasis of cancer cells.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed